Back to XENE

Octagon Capital Advisors LP → XENE

Octagon Capital Advisors LP XENE Position History

Xenon Pharmaceuticals Inc. • Healthcare

Quarters held
3
Latest value
$15.6M
Q3 2026
Peak value
$29.6M
First seen
Q1 2026

Dollar value over time

Show data table
PeriodPosition value
Q1 2026$28.5M
Q2 2026$29.6M
Q3 2026$15.6M

Quarter-by-quarter history

Every disclosed snapshot of the position

QuarterValueShares% PortfolioChange
Q3 2026$15.6M420.0K——
Q2 2026$29.6M490.0K——
Q1 2026$28.5M490.0K——

Other funds holding XENE

Other Octagon Capital Advisors LP positions

DNTH

DIANTHUS THERAPEUTICS INC

$179.5M
DNTH

DIANTHUS THERAPEUTICS INC

$163.4M
DNTH

DIANTHUS THERAPEUTICS INC

$148.5M
DFTX

DEFINIUM THERAPEUTICS INC

$138.8M
AAVXF

ABIVAX SA

$132.3M
AAVXF

ABIVAX SA

$102M
DNTH

DIANTHUS THERAPEUTICS INC

$99.6M
AAVXF

ABIVAX SA

$98.3M